Immunization and Vaccination are crucial components of public health strategies aimed at preventing infectious diseases and protecting individuals and communities from their harmful effects. While the terms "immunization" and "vaccination" are often used interchangeably, they refer to distinct but related concepts within the realm of disease prevention.
Vaccination refers specifically to the process of administering a vaccine, a biological preparation that stimulates the immune system to recognize and mount a protective response against a particular pathogen, such as a virus or bacterium. Vaccines can contain live, weakened, or inactivated forms of the pathogen, as well as specific components or antigens derived from the pathogen. Immunization, on the other hand, refers to the overall process of inducing immunity to a disease through vaccination or by other means, such as natural infection. Immunization can lead to the development of long-lasting immunity, providing protection against future encounters with the pathogen.
The goal of immunization and vaccination programs is to achieve herd immunity, also known as community immunity, where a significant proportion of the population is immune to a disease, thereby reducing the overall transmission and prevalence of the disease within the community. This not only protects vaccinated individuals but also provides indirect protection to those who are not vaccinated, such as infants, elderly individuals, and those with compromised immune systems. Immunization and vaccination have been instrumental in controlling and eradicating many infectious diseases that were once widespread and deadly. Diseases such as smallpox, polio, and measles have been effectively controlled or eliminated in many parts of the world through vaccination campaigns and routine immunization programs.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India